A group of investors completed the acquisition of 15.5831% stake in Anhui Zhongsheng Suyuan Biotechnology Co., Ltd. from Youngy Health Co., Ltd..
June 21, 2022
Share
Beijing Junlian Huikang Equity Investment Partnership (Limited Partnership), Suzhou City China Merchants Phase I Emerging Industry Fund Partnership (Limited Partnership), Chaozhou Guangfa Xinde Venture Capital Fund Partnership (Limited Partnership), Zhuhai Guangfa Xinde Xinzhou No. 1 Venture Capital Fund (Limited Partnership) and Zhuhai Junlian Kai'an Venture Capital Partnership (Limited Partnership) agreed to acquire 15.5831% stake in Anhui Zhongsheng Suyuan Biotechnology Co., Ltd. from Youngy Health Co., Ltd. (SZSE:300247) for approximately CNY 211 million on May 6, 2022. As per the transaction, Beijing Junlian Huikang Equity Investment Partnership (Limited Partnership) will acquire 3.2524% stake, Suzhou City China Merchants Phase I Emerging Industry Fund Partnership (Limited Partnership) will acquire 6.5048% stake, Chaozhou Guangfa Xinde Venture Capital Fund Partnership (Limited Partnership) will acquire 1.4706% stake, Zhuhai Guangfa Xinde Xinzhou No. 1 Venture Capital Fund (Limited Partnership) will acquire 1.1029% stake and Zhuhai Junlian Kai'an Venture Capital Partnership (Limited Partnership) acquire 3.2524% stake of Anhui Zhongsheng Suyuan Biotechnology Co., Ltd. As on December 31, 2021, Anhui Zhongsheng Suyuan Biotechnology Co., Ltd. generated, total assets of CNY 111.9 million, net assets of CNY 87.9 million, Operating income of CNY 17.9 million and net loss of CNY 27.4 million. The transaction is approved by board of directors of Youngy Health Co., Ltd. and is subject to shareholder's approval of Youngy Health Co., Ltd. As of June 7, 2022, company has received equity transfer payment of CNY 108.1, accounting for 51% of the equity transfer payment receivable.
Beijing Junlian Huikang Equity Investment Partnership (Limited Partnership), Suzhou City China Merchants Phase I Emerging Industry Fund Partnership (Limited Partnership), Chaozhou Guangfa Xinde Venture Capital Fund Partnership (Limited Partnership), Zhuhai Guangfa Xinde Xinzhou No. 1 Venture Capital Fund (Limited Partnership) and Zhuhai Junlian Kai'an Venture Capital Partnership (Limited Partnership) completed the acquisition of 15.5831% stake in Anhui Zhongsheng Suyuan Biotechnology Co., Ltd. from Youngy Health Co., Ltd. (SZSE:300247) on June 22, 2022.
Youngy Health Co., Ltd., formerly LeKing Wellness Co.,Ltd., is a China-based company principally engaged in the research and development, production and distribution of household far infrared therapy equipment. The Companyâs main products include far infrared therapy houses, massage armchairs, small massage home appliances, portable sauna equipment, air purifiers and fitness apparatuses, among others. The Company distributes its products in domestic market and to overseas markets.
YOUNGY HEALTH CO., LTD. 
